Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 108, Issue 1, Pages djv302
Publisher
Oxford University Press (OUP)
Online
2015-10-15
DOI
10.1093/jnci/djv302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults
- (2014) Daniel C. Beachler et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
- (2014) Allan Hildesheim et al. VACCINE
- Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
- (2013) M. Schiffman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
- (2013) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- (2013) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study
- (2013) Aimée R Kreimer et al. LANCET
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
- (2013) Rolando Herrero et al. PLoS One
- Rates and Determinants of Oral Human Papillomavirus Infection in Young Men
- (2013) Zoe R. Edelstein et al. SEXUALLY TRANSMITTED DISEASES
- Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials
- (2012) M. Safaeian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prevalence of Oral HPV Infection in the United States, 2009-2010
- (2012) Maura L. Gillison et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of and Risk Factors for Anal Human Papillomavirus Infection Among Young Healthy Women in Costa Rica
- (2012) Felipe A. Castro et al. JOURNAL OF INFECTIOUS DISEASES
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
- (2011) X Castellsagué et al. BRITISH JOURNAL OF CANCER
- Associations between Oral HPV16 Infection and Cytopathology: Evaluation of an Oropharyngeal "Pap-Test Equivalent" in High-Risk Populations
- (2011) C. Fakhry et al. Cancer Prevention Research
- Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine
- (2011) Francis J. Dessy et al. Human vaccines & immunotherapeutics
- Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
- (2011) A. Szarewski et al. INTERNATIONAL JOURNAL OF CANCER
- Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3
- (2011) Ana Cecilia Rodríguez et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
- (2010) M. Safaeian et al. JNCI-Journal of the National Cancer Institute
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
- (2008) Rolando Herrero et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now